$RXII breakout candles $3.32 called 8/12/14 $2.60
Post# of 63696
called 8/12/14 $2.60
Shares Outstanding: 16.10M
Float: 11.47M
10-Q 8/14/14
56% Buy
Website
Press Releases
Thursday, August 14, 2014
RXi Pharmaceuticals Reports Financial Results for the Second Quarter of 2014PR Newswire
Thursday, August 7, 2014
RXi Pharmaceutical Corporation (NASDAQ: RXII) to Ring The NASDAQ Stock Market Closing BellGlobeNewswire
Monday, August 4, 2014
RXi Pharmaceuticals to Ring the NASDAQ Stock Market Closing BellPR Newswire
Wednesday, July 30, 2014
RXi Pharmaceuticals Expands Clinical Program with Initiation of Third Phase 2a Study with RXI-109 for Treatment of Hypertrophic ScarsPR Newswire
Wednesday, July 9, 2014
What RXi Pharmaceuticals’ Move to the Russell Microcap Index MeansAccesswire
Monday, July 7, 2014
RXi Pharmaceuticals Appoints Peter Campochiaro M.D. to its Scientific Advisory BoardPR Newswire
Wednesday, July 2, 2014
RXi Pharmaceuticals Celebrates Expansion of its Operations in MassachusettsPR Newswire
Wednesday, June 25, 2014
RXi Pharmaceuticals Set to Join Russell Microcap IndexPR Newswire
Monday, June 9, 2014
RXi Pharma Advances sd-rxRNA Platform with Key PatentAccesswire
Tuesday, May 27, 2014
RXi Pharmaceuticals to Present at the Jefferies 2014 Global Healthcare ConferencePR Newswire
Thursday, May 22, 2014
RXi Pharmaceuticals Granted US Notice of Allowance Covering Self-Delivering (sd-rxRNA) Technology PlatformPR Newswire
Wednesday, May 14, 2014
RXi Pharmaceuticals Reports Financial Results for the First Quarter of 2014PR Newswire
Friday, May 2, 2014
RXi Pharmaceuticals Announces Positive Results with RXI-109 in the Eyes of Cynomolgus Monkeys as Part of a Dose Range Finding StudyPR Newswire